Download Reveal LINQ ™ Insertable Cardiac Monitor (ICM) with

Reveal LINQ™ Insertable Cardiac Monitor (ICM) with TruRhythm™
Detection
The Medtronic Reveal LINQ™ Insertable Cardiac
Monitor (ICM) with TruRhythm™ Detection is an
insertable cardiac monitor providing smarter
detection of irregular heartbeats. The device
offers the most advanced detection algorithms,
maintaining cardiac monitoring sensitivity while
significantly reducing false episodes of
bradycardia, pause and atrial fibrillation (AF).
The enhancements of the Reveal LINQ ICM with
TruRhythm Detection streamline data review so
physicians can make decisions more accurately
and quickly for patients at risk for cardiac arrhythmias.
Continuous, Long-Term Cardiac Monitoring
Continuous long-term cardiac monitoring with the Reveal LINQ ICM with TruRhythm Detection can help
diagnose the most difficult to detect arrhythmias associated with conditions such as unexplained
syncope and cryptogenic stroke that are not easily identified with traditional, short-term monitors.
Device Features

Smart Filtering Brady & Pause Algorithms: TruRhythm Detection algorithms better sense
premature ventricular contractions (extra, abnormal heartbeat that begins in the lower
chambers of the heart), resulting in a 95 percent reduction in false bradycardia and 47 percent
reduction in false pause episodes when compared with its predecessor, the Reveal LINQ ICM.1

Self-Learning Atrial Fibrillation Algorithm: TruRhythm Detection AF algorithm learns and
adapts to a patients’ heart rhythm over time, resulting in a 49 percent reduction in false AF
episodes when compared with Reveal LINQ ICM.2

Small and Minimally Invasive: The smallest cardiac monitor available (~1 cc), it’s
approximately one-third the size of an AAA battery and has a battery life of 3 years. The device
is placed just beneath the skin through a small incision of less than 1 cm in the upper left side
of the chest. Its presence is often nearly undetectable to the naked eye once the incision has
healed.

Advanced Technology: The device communicates wirelessly with a patient bedside monitor
that uploads device data to the Medtronic CareLink® network, allowing physicians to
continuously and wirelessly monitor a patient’s heartbeat.

MR-Conditional: Patients with the Reveal LINQ ICM with TruRhythm Detection have access to
magnet resonance imaging (MRI), the gold standard in diagnosis for many diseases.
The Reveal LINQ with TruRhythm Detection received FDA 510(k) clearance in February 2017.
1
2
TruRhythm Detection Algorithms. Medtronic data on file. 2017.
TruRhythm Detection Algorithms. Medtronic data on file. 2017